Internet-Based CBT and Online Counseling for Male Sexual Dysfunction: Systematic Review

21 studies found online CBT improved erectile function; ED remission rates were 20–30%, but fewer than 60% of participants stayed engaged

Journal: Sexual Medicine Reviews | Published: 2026-04-02 | Type: Systematic Review | PMID: 41926207 Authors: Arya Srisadono, Muhammad Adamas, Cennikon Pakpahan (Universitas Airlangga, Indonesia); Camil C Branco (University of Barcelona, Spain) Funding/COI: Not reported

Summary

A systematic review of 21 studies found that internet-based cognitive behavioral therapy (ICBT) and online psychoeducation improved erectile function and sexual satisfaction compared to control conditions. Remission rates for ED reached 20–30% across included studies, with most programs running 6–12 weeks. The headline caveat: fewer than 60% of participants actually completed the interventions.

Claims

Study Quality

This is a PRISMA-compliant systematic review—appropriate methodology for synthesizing a heterogeneous literature. The included studies span both RCTs and observational designs, a deliberate choice to capture feasibility and real-world engagement data alongside efficacy signals, but one that makes pooling results difficult. The review covers 17 years of literature (2007–2024), a period when digital intervention formats changed substantially; early web-based tools and contemporary mobile-integrated platforms are not equivalent, and the review does not stratify by era.

No meta-analysis was attempted, which is defensible given the stated heterogeneity in outcome measures, intervention types, and control conditions. Without quantitative pooling, the 20–30% remission figure should be read as a range across disparate studies rather than a pooled estimate with confidence intervals.

Red Flags

Strengths

Verdict

A workmanlike systematic review confirming what the prior literature suggested: online CBT-type interventions can move the needle on ED, with remission rates in the 20–30% range across a heterogeneous set of 21 studies. The missing funding and COI disclosures are sloppy for a 2026 publication. The larger problem is that sub-60% adherence undermines every efficacy claim—if most participants drop out, you're measuring outcomes in motivated completers, not a generalizable treatment population. Worth reading for the breadth of the synthesis, but the absence of a meta-analysis and the wide variation in intervention formats mean there's no clean effect size to extract.